Statements (55)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:Company
|
| gptkbp:bfsLayer |
4
|
| gptkbp:bfsParent |
gptkb:Foundation_Medicine
|
| gptkbp:analyzes |
hematologic malignancies
copy number alterations gene fusions |
| gptkbp:approves |
gptkb:FDA
|
| gptkbp:based_on |
comprehensive genomic data
|
| gptkbp:developed_by |
gptkb:Foundation_Medicine
|
| https://www.w3.org/2000/01/rdf-schema#label |
Foundation One Heme
|
| gptkbp:includes |
DNA sequencing
RNA sequencing |
| gptkbp:innovation |
cancer diagnostics.
|
| gptkbp:is_a_resource_for |
oncology research
|
| gptkbp:is_a_tool_for |
biomarker identification
hematologic cancers |
| gptkbp:is_aimed_at |
improving therapeutic strategies
|
| gptkbp:is_analyzed_in |
treatment response
genetic predisposition |
| gptkbp:is_associated_with |
improved patient outcomes
|
| gptkbp:is_available_for |
adult patients
|
| gptkbp:is_designed_for |
clinical decision-making
oncologists cancer patients |
| gptkbp:is_designed_to |
detect genetic alterations
|
| gptkbp:is_involved_in |
patient stratification
|
| gptkbp:is_part_of |
gptkb:municipality
molecular diagnostics cancer diagnostics molecular oncology personalized cancer care integrated cancer care |
| gptkbp:is_recognized_by |
gptkb:hospital
targeted therapies clinical trial options |
| gptkbp:is_recognized_for |
its accuracy
|
| gptkbp:is_tested_for |
blood cancers
|
| gptkbp:is_used_for |
comprehensive genomic profiling
|
| gptkbp:is_used_in |
clinical trials
clinical settings |
| gptkbp:is_utilized_in |
research studies
healthcare providers pharmacogenomics |
| gptkbp:key |
cancer treatment planning
|
| gptkbp:launched |
gptkb:2017
|
| gptkbp:monitors |
disease progression
|
| gptkbp:part_of |
Foundation One portfolio
|
| gptkbp:products |
gptkb:Company
|
| gptkbp:provides |
mutation analysis
|
| gptkbp:provides_information_on |
treatment decisions
treatment pathways tumor mutational burden |
| gptkbp:services |
gptkb:Foundation_Medicine
|
| gptkbp:supports |
precision medicine
|
| gptkbp:utilizes |
next-generation sequencing
|